USP 800 and The National Institute for Occupational Safety and Health (NIOSH) recommends that employers develop a medical surveillance program to monitor the safety of the employees working with hazardous drugs, including wipe sampling every 6 months.
This recommendation includes using baseline data and ongoing monitoring of environmental hazards as a way to assess the potential risk of employee exposure to hazardous drugs. Read More >
ChemoGLO is passionate about the impacts of hazardous drugs on patients and healthcare workers. Evaluating environmental exposure to chemotherapy in the workplace is the first step in providing a healthier, safer work environment. ChemoGLO focuses on hazardous drug detection and removal in clinical, laboratory, and institutional settings by offering two USP 800 compliant products.
